LogicMark (LGMK) 10-Q12 Aug 222022 Q2 Quarterly reportFinancial data

Company Profile

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2022	Aug. 09, 2022
Document Information Line Items
Entity Registrant Name	LogicMark, Inc.
Trading Symbol	LGMK
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		9,608,937
Amendment Flag	false
Entity Central Index Key	0001566826
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jun. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-36616
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-0678374
Entity Address, Address Line One	2801 Diode Lane
Entity Address, City or Town	Louisville
Entity Address, State or Province	KY
Entity Address, Postal Zip Code	40299
City Area Code	(502)
Local Phone Number	442-7911
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current Assets
Cash	$ 11,144,085	$ 12,044,415
Restricted cash	59,988	210,131
Accounts receivable, net	258,509	98,749
Inventory, net	622,893	1,237,280
Prepaid expenses and other current assets	773,509	849,190
Total Current Assets	12,858,984	14,439,765
Property and equipment:
Equipment	412,135	410,444
Furniture and fixtures	35,761	35,761
Website and other	171,217	9,427
Property and equipment, gross	619,113	455,632
Accumulated depreciation	(446,975)	(455,632)
Property and equipment, net	172,138
Right-of-use assets, net	216,345	248,309
Product development costs	269,268
Goodwill	10,958,662	10,958,662
Other intangible assets, net of amortization of $4,516,204 and $4,127,920, respectively	4,093,171	4,476,647
Total Assets	28,568,568	30,123,383
Current Liabilities
Accounts payable	788,511	492,431
Accrued expenses	862,223	849,285
Total Current Liabilities	1,650,734	1,341,716
Other long-term liabilities	349,006	385,196
Total Liabilities	1,999,740	1,726,912
Commitments and Contingencies (Note 8)
Series C Redeemable Preferred Stock
Series C Redeemable Preferred Stock, par value $0.0001 per share: 2,000 shares designated; 200 shares issued and outstanding as of June 30, 2022 and December 31, 2021	1,807,300	1,807,300
Stockholders’ Equity
Preferred Stock, par value $0.0001 per share: 10,000,000 shares authorized
Series F Preferred Stock, par value $0.0001 per share: 1,333,333 shares designated; 173,333 shares issued and outstanding as of June 30, 2022, aggregate liquidation preference of $520,000 as of June 30, 2022, and December 31, 2021	520,000	520,000
Common Stock, par value $0.0001 per share: 100,000,000 shares authorized; 9,608,937 and 9,163,039 issued and outstanding as of June 30, 2022 and December 31, 2021	961	917
Additional paid-in capital	105,318,990	104,725,115
Accumulated deficit	(81,078,423)	(78,656,861)
Total Stockholders’ Equity	24,761,528	26,589,171
Total Liabilities, Series C Redeemable Preferred Stock and Stockholders’ Equity	$ 28,568,568	$ 30,123,383

Condensed Balance Sheets (Una_2

Condensed Balance Sheets (Unaudited) (Parentheticals) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Other intangible assets, net of amortization (in Dollars)	$ 4,516,204	$ 4,127,920
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized	10,000,000	10,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	9,608,937	9,163,039
Common stock, shares outstanding	9,608,937	9,163,039
Series C Preferred Stock
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares designated	2,000	2,000
Preferred stock, shares issued	200	200
Preferred stock, shares outstanding	200	200
Series F Preferred Stock
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares designated	1,333,333	1,333,333
Preferred stock, shares issued	173,333	173,333
Preferred stock, shares outstanding	173,333	173,333
Preferred stock, liquidation preference (in Dollars)	$ 520,000	$ 520,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended			6 Months Ended
Condensed Statements of Operations (Unaudited) - USD ($)	Jun. 30, 2022	Jun. 30, 2021	[1]	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Revenues	$ 3,367,692	$ 2,782,575		$ 7,018,380	$ 5,221,256	[1]
Costs of goods sold	1,364,586	1,074,878		2,811,891	2,064,265	[1]
Gross Profit	2,003,106	1,707,697		4,206,489	3,156,991	[1]
Operating Expenses
Direct operating cost	336,544	255,859		810,987	500,528	[1]
Selling and marketing	275,011	89,781		464,216	169,904	[1]
Research and development	204,592	279,450		467,077	593,344	[1]
General and administrative	2,115,700	1,078,258		4,451,647	2,457,327	[1]
Other expense	2,000	14,697		32,084	25,268	[1]
Depreciation and amortization	194,691	201,324		389,054	405,181	[1]
Total Operating Expenses	3,128,538	1,919,369		6,615,065	4,151,552	[1]
Operating Loss	(1,125,432)	(211,672)		(2,408,576)	(994,561)	[1]
Other Income and (Expense)
Interest income (expense)	13,159	(389,541)		13,159	(1,250,789)	[1]
Forgiveness of Paycheck Protection Program loan and accrued interest		45,466			349,176	[1]
Warrant modification expense					(2,881,729)	[1]
Total Other Expense, Net	13,159	(344,075)		13,159	(3,783,342)	[1]
Loss before Income Taxes	(1,112,273)	(555,747)		(2,395,417)	(4,777,903)	[1]
Income tax (expense) benefit
Net Loss	(1,112,273)	(555,747)		(2,395,417)	(4,777,903)	[1]
Preferred stock dividends	(88,144)	(615,000)		(176,144)	(2,170,801)	[1]
Net Loss Applicable to Common Stockholders	$ (1,200,417)	$ (1,170,747)		$ (2,571,561)	$ (6,948,704)
Net Loss Per Share - Basic and Diluted (in Dollars per share)	$ (0.13)	$ (0.22)		$ (0.27)	$ (1.37)	[1]
Weighted Average Number of Common Shares Outstanding - Basic and Diluted (in Shares)	9,594,746	5,331,190		9,538,666	5,076,636	[1]

[1]Expenses in 2021 have been reclassified to conform to the 2022 presentation format.

Condensed Statements of Opera_2

Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Net Loss Per Share - Basic and Diluted	$ (0.13)	$ (0.22)	$ (0.27)	$ (1.37)
Weighted Average Number of Common Shares Outstanding - Basic and Diluted	9,594,746	5,331,190	9,538,666	5,076,636

Condensed Changes in Stockholde

Condensed Changes in Stockholders’ Equity (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2020		$ 407	$ 74,586,801	$ (65,427,998)	$ 9,159,210
Balance (in Shares) at Dec. 31, 2020		4,061,997
Issuance of stock options for services			80,000		80,000
Issuance of Series E preferred stock, net	$ 4,000,003				4,000,003
Issuance of Series E preferred stock, net (in Shares)	1,476,016
Conversion of Series E preferred stock to common stock	$ (4,000,003)	$ 29	3,999,974
Conversion of Series E preferred stock to common stock (in Shares)	(1,476,016)	295,203
Deemed dividend related to beneficial conversion feature of Series E preferred stock			1,480,801	(1,480,801)
Exercise of common stock purchase warrants on a cash basis		$ 54	6,669,957		6,670,011
Exercise of common stock purchase warrants on a cash basis (in Shares)		536,774
Exercise of common stock purchase warrants on a cashless basis		$ 42	(42)
Exercise of common stock purchase warrants on a cashless basis (in Shares)		423,933
Warrant modification expense recorded in connection with the issuance of replacement warrants			2,881,729		2,881,729
Shares issued in connection with the management incentive plan for 2018 and 2019		$ 1	80,455		80,456
Shares issued in connection with the management incentive plan for 2018 and 2019 (in Shares)		13,283
Fees incurred in connection with equity offerings			(44,156)		(44,156)
Series C Redeemable Preferred stock dividends			(690,000)		(690,000)
Net loss				(4,777,903)	(4,777,903)	[1]
Balance at Jun. 30, 2021		$ 533	89,045,519	(71,686,702)	17,359,350
Balance (in Shares) at Jun. 30, 2021		5,331,190
Balance at Mar. 31, 2021		$ 533	89,620,519	(71,130,955)	18,490,097
Balance (in Shares) at Mar. 31, 2021		5,331,190
Issuance of stock options for services			40,000		40,000
Series C Redeemable Preferred stock dividends			(615,000)		(615,000)
Net loss				(555,747)	(555,747)	[1]
Balance at Jun. 30, 2021		$ 533	89,045,519	(71,686,702)	17,359,350
Balance (in Shares) at Jun. 30, 2021		5,331,190
Balance at Dec. 31, 2021	$ 520,000	$ 917	104,725,115	(78,656,861)	26,589,171
Balance (in Shares) at Dec. 31, 2021	173,333	9,163,039
Issuance of stock options for services			215,614		215,614
Shares issued as stock compensation		$ 44	528,261		528,305
Shares issued as stock compensation (in Shares)		445,898
Series C Redeemable Preferred stock dividends			(150,000)		(150,000)
Series F Preferred stock dividends				(26,145)	(26,145)
Net loss				(2,395,417)	(2,395,417)
Balance at Jun. 30, 2022	$ 520,000	$ 961	105,318,990	(81,078,423)	24,761,528
Balance (in Shares) at Jun. 30, 2022	173,333	9,608,937
Balance at Mar. 31, 2022	$ 520,000	$ 959	105,279,875	(79,953,006)	25,847,828
Balance (in Shares) at Mar. 31, 2022	173,333	9,593,378
Issuance of stock options for services			(169,722)		(169,722)
Shares issued as stock compensation		$ 2	283,837		283,839
Shares issued as stock compensation (in Shares)		15,559
Series C Redeemable Preferred stock dividends			(75,000)		(75,000)
Series F Preferred stock dividends				(13,144)	(13,144)
Net loss				(1,112,273)	(1,112,273)
Balance at Jun. 30, 2022	$ 520,000	$ 961	$ 105,318,990	$ (81,078,423)	$ 24,761,528
Balance (in Shares) at Jun. 30, 2022	173,333	9,608,937

[1]Expenses in 2021 have been reclassified to conform to the 2022 presentation format.

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
Condensed Statements of Cash Flows (Unaudited) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Cash Flows from Operating Activities
Net loss	$ (2,395,417)	$ (4,777,903)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	770	27,404
Stock based compensation	743,919	80,000
Amortization of debt discount		111,239
Amortization of intangible assets	388,284	377,777
Amortization of deferred debt issuance costs		594,914
Non-cash charge for modification of warrant terms		2,881,729
Forgiveness of Paycheck Protection Plan loans and accrued interest		(349,176)
Changes in operating assets and liabilities:
Accounts receivable	(159,760)	9,147
Inventory	614,387	21,698
Prepaid expenses and other current assets	75,681	(201,482)
Accounts payable	296,080	(1,051,140)
Accrued expenses	(17,433)	502,570
Net Cash Used in Operating Activities	(453,489)	(1,773,223)
Cash flows from Investing Activities
Purchase of equipment and website development	(172,908)
Product development costs	(269,268)
Purchase of intangible assets	(4,808)
Net Cash Used by Investing Activities	(446,984)
Cash flows from Financing Activities
Proceeds from sale of common stock and warrants		6,670,011
Proceeds received in connection with issuance of Series E preferred stock, net		4,000,003
Term loan repayment		(10,031,250)
Fees paid in connection with equity offerings		(10,030)
Preferred Stock Dividends	(150,000)
Net Cash (Used in) Provided by Financing Activities	(150,000)	628,734
Net Increase in Cash and Restricted Cash	(1,050,473)	(1,144,489)
Cash and Restricted Cash - Beginning of Year	12,254,546	4,537,546
Cash and Restricted Cash - End of Period	11,204,073	3,393,057
Cash paid during the periods for:
Interest		592,237
Taxes		47,874
Non-cash investing and financing activities:
Accrued fees incurred in connection with equity offerings		34,126
Accrued preferred stock dividends	26,145	690,000
Shares issued in connection with prior year accrual		80,456
Conversion of Series E preferred stock to common stock		$ 4,000,003

Organization and Principal Busi

Organization and Principal Business Activities	6 Months Ended
Organization and Principal Business Activities	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND PRINCIPAL BUSINESS ACTIVITIES	NOTE 1 - ORGANIZATION AND PRINCIPAL BUSINESS ACTIVITIES LogicMark, Inc. (“LogicMark” or the “Company”) was incorporated in the State of Delaware on February 8, 2012. LogicMark provides personal emergency response systems (PERS), health communications devices, and Internet of Things technology that creates a connected care platform. The Company’s devices give people the ability to receive care at home and the confidence to age independently. LogicMark revolutionized the PERS industry by incorporating two-way voice communication technology directly in the medical alert pendant and providing life-saving technology at a price point everyday consumers could afford. The PERS technologies are sold through dealers and distributors, as well as directly to the United States Veterans Health Administration.

Liquidity and Management Plans

Liquidity and Management Plans	6 Months Ended
Liquidity and Management Plans	Jun. 30, 2022
Liquidity and Management Plans Table [Abstract]
LIQUIDITY AND MANAGEMENT PLANS	NOTE 2 - LIQUIDITY AND MANAGEMENT PLANS The Company generated an operating loss of $2,408,576 and a net loss of $2,395,417 for the six months ended June 30, 2022. As of June 30, 2022, the Company had cash and stockholders’ equity of $11,144,085 and $24,761,528, respectively. As of June 30, 2022, the Company had working capital of $11,208,250 compared to working capital on December 31, 2021, of $13,098,049. Given the Company’s cash position on June 30, 2022, and its projected cash flow from operations, the Company believes that it will have sufficient capital to sustain operations for a period of one year following the date of this filing.

Basis of Presentation

Basis of Presentation	6 Months Ended
Basis of Presentation	Jun. 30, 2022
Accounting Policies [Abstract]
BASIS OF PRESENTATION	NOTE 3 - BASIS OF PRESENTATION The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting. In the opinion of management, the information herein reflects all adjustments, consisting only of normal recurring adjustments except as otherwise noted, considered necessary for a fair statement of results of operations, financial position, stockholders’ equity, and cash flows. The results for the interim periods presented are not necessarily indicative of the results expected for any future period. The following information should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Net loss per share and all share data for the three and six months ended June 30, 2021, have been retroactively adjusted to reflect the reverse stock split that occurred in October 2021, in accordance with ASC 260-10-55-12, Restatement of EPS Data. See Note 6. Certain prior year amounts have been reclassified for consistency with the current year’s presentation. These reclassifications had no effect on the reported results of operations.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
Summary of Significant Accounting Policies	Jun. 30, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES USE OF ESTIMATES IN THE FINANCIAL STATEMENTS The preparation of financial statements in conformity with generally accepted accounting principles in the United States (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s management evaluates these significant estimates and assumptions, including those related to the fair value of acquired assets and liabilities, stock-based compensation, income taxes, allowance for doubtful accounts, long-lived assets, and inventories, and other matters that affect the financial statements and disclosures. Actual results could differ from those estimates. CASH The Company considers all highly liquid securities with an original maturity date of three months or less when purchased to be cash equivalents. Due to their short-term nature, cash equivalents are carried at cost, which approximates fair value. On June 30, 2022, and December 31, 2021, the Company had no cash equivalents, respectively. RESTRICTED CASH On June 30, 2022, and December 31, 2021, the Company had restricted cash of $59,988 and $210,131, respectively. Restricted cash includes amounts held back by the Company’s third-party credit card processor for potential customer refunds, claims, and disputes and held as collateral for company credit cards. CONCENTRATIONS OF CREDIT RISK Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its cash balances in large well-established financial institutions located in the United States. At times, the Company’s cash balances may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (FDIC) insurance limits. REVENUE RECOGNITION The Company’s revenues consist of product sales to either end customers or distributors. The Company’s revenues are derived from contracts with customers, which are in most cases customer purchase orders. For each contract, the promise to transfer the control of the products, each of which is individually distinct, is considered to be the identified performance obligation. As part of the consideration promised in each contract, the Company evaluates the customer’s credit risk. Our contracts do not have any financing components, as payment terms are generally due Net-30 days after the invoice date. The Company’s products are almost always sold at fixed prices. In determining the transaction price, we evaluate whether the price is subject to any refunds, due to product returns or adjustments due to volume discounts, rebates, or price concessions to determine the net consideration we expect to be entitled to. The Company’s sales are recognized at a point-in-time under the core principle of recognizing revenue when control transfers to the customer, which generally occurs when the Company ships or delivers the product from its fulfillment center to our customers, when our customer accepts and has the legal title of the goods, and the Company has a present right to payment for such goods. Based on the respective contract terms, most of our contract revenues are recognized either (i) upon shipment based on free on board (FOB) shipping point, or (ii) when the product arrives at its destination. For the six months ended June 30, 2022, and 2021, none of our sales were recognized over time. SALES TO DISTRIBUTORS AND RESELLERS Sales to certain distributors and resellers are made under terms allowing limited rights of return of the Company’s products held in their inventory or upon sale to their end customers. The Company maintains a reserve for unprocessed and estimated future price adjustments claims and returns as a refund liability. The reserve is recorded as a reduction to revenue in the same period that the related revenue is recorded and is calculated based on an analysis of historical claims and returns over a period of time to appropriately account for current pricing and business trends. Similarly, sales returns and allowances are recorded based on historical return rates, as a reduction in revenue with a corresponding reduction to cost of sales for the estimated cost of inventory that is expected to be returned. These reserves were not material on the Condensed Balance Sheets on June 30, 2022, and December 31, 2021. SHIPPING AND HANDLING Amounts billed to customers for shipping and handling are included in revenues. The related freight charges incurred by the Company are included in the cost of goods sold and were $181,551 and $373,213, respectively, for the three and six months ended June 30, 2022, and $118,136 and $224,561, respectively, for the three and six months ended June 30, 2021. ACCOUNTS RECEIVABLE For the three and six months ended June 30, 2022, and the year ended December 31, 2021, the Company’s revenues primarily included shipments of the LogicMark products. The terms and conditions of these sales provided certain customers with trade credit terms. In addition, these sales were made to the retailers with no rights of return and are subject to the normal warranties offered to the ultimate consumer for product defects. Accounts receivable are stated at net realizable value. The Company regularly reviews accounts receivable balances and adjusts the receivable reserves as necessary whenever events or circumstances indicate the carrying value may not be recoverable. On June 30, 2022, and December 31, 2021, the Company had an allowance for doubtful accounts of $3,209 and $5,411, respectively. INVENTORY The Company measures inventory at the lower of cost or net realizable value, defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The Company performs regular reviews of inventory quantities on hand and evaluates the realizable value of its inventories. The Company adjusts the carrying value of the inventory as necessary with estimated valuation reserves for excess, obsolete, and slow-moving inventory by comparing the individual inventory parts to forecasted product demand or production requirements. The inventory is valued at the lower of cost or net realizable value with cost determined using the first-in, first-out method. As of June 30, 2022, inventory was comprised of $622,893 in finished goods on hand. As of December 31, 2021, inventory was comprised of $1,237,280 in finished goods on hand. The Company is required to prepay for certain inventory with certain vendors until credit terms can be established. As of June 30, 2022, and December 31, 2021, $599,112 and $559,938 respectively, of prepayments made for inventory are included in prepaid expenses and other current assets on the balance sheet. LONG-LIVED ASSETS Long-lived assets, such as property and equipment, and other intangibles are evaluated for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. When indicators exist, the Company tests for the impairment of the definite-lived assets based on the undiscounted future cash flow the assets are expected to generate over their remaining useful lives, compared to the carrying value of the assets. If the carrying amount of the assets is determined not to be recoverable, a write-down to fair value is recorded. Management estimates future cash flows using assumptions about expected future operating performance. Management’s estimates of future cash flows may differ from actual cash flow due to, among other things, technological changes, economic conditions, or changes to the Company’s business operations. PROPERTY AND EQUIPMENT Property and equipment consisting of equipment, furniture and fixtures, and website and other are stated at cost. The costs of additions and improvements are generally capitalized and expenditures for repairs and maintenance are expensed in the period incurred. When items of property and equipment are sold or retired, the related costs and accumulated depreciation are removed from the accounts, and any gain or loss is included in income. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful life of the respective asset as follows: Equipment 5 years Furniture and fixtures 3 to 5 years Website and other 2 to 3 years GOODWILL Goodwill is reviewed annually in the fourth quarter, or when circumstances indicate that an impairment may have occurred. The Company first performs a qualitative assessment of goodwill impairment, which considers factors such as market conditions, performance compared to forecast, business outlook, and unusual events. If the qualitative assessment indicates a possible goodwill impairment, goodwill is then quantitatively tested for impairment. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative test. If a quantitative goodwill impairment test is required, the fair value is determined using a variety of assumptions including estimated future cash flows using applicable discount rates (income approach) and comparisons to other similar companies (market approach). OTHER INTANGIBLE ASSETS The Company’s intangible assets are related to the acquisition of LogicMark, LLC and are included in other intangible assets in the Company’s balance sheet on June 30, 2022, and December 31, 2021. On June 30, 2022, Other intangible assets, net of amortization, are comprised of patents of $1,887,784; trademarks of $883,579; and customer relationships of $1,321,808. On December 31, 2021, the other intangible assets are comprised of patents of $2,072,984; trademarks of $915,619; and customer relationships of $1,488,044. The Company amortizes these intangible assets using the straight-line method over their estimated useful lives which for the patents, trademarks, and customer relationships are 11 years, 20 years, and 10 years, respectively. During the three and six months ended June 30, 2022, the Company recorded amortization expense of $194,178 and $388,284, respectively. During the three and six months ended June 30, 2021, the Company recorded amortization expense of $189,932 and $377,777, respectively. As of June 30, 2022, total amortization expense estimated for the remainder of fiscal year 2022 is $373,531, and for each of the next five fiscal years, the total amortization expense is estimated to be as follows: 2023 - $761,815; 2024 - $761,815; 2025 - $761,815; 2026 - $618,790; and 2027- $272,235. CONVERTIBLE INSTRUMENTS The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion options. The accounting standards require companies to separate conversion options from their host instruments and account for them as free-standing derivatives according to certain criteria. The criteria include circumstances in which (i) the economic characteristics and risks of the embedded derivative are not closely related to the economic characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative and the host contract is not re-measured at fair value under generally accepted accounting principles with changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative would be considered a derivative. The derivative is subsequently marked to market at each reporting date based on the current fair value, with the changes in fair value reported in the results of operations. Conversion options with variable settlement features such as provisions to adjust the conversion price upon subsequent issuances at exercise prices more favorable than that in the hybrid contract generally result in their separation from the host instrument. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. The debt discounts under these arrangements are amortized over the earlier of (i) the term of the related debt using the straight-line method which approximates the interest rate method or (ii) conversion of the debt. The amortization of debt discount is included as interest expense included in other income and expenses in the statements of operations. DERIVATIVE FINANCIAL INSTRUMENTS The Company does not use derivatives to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. Derivative financial instruments accounted for as liabilities are initially recorded at fair value and then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivatives, the Company uses the Black-Scholes or binomial option valuation model to value the derivatives at inception and on subsequent valuation dates. The Company accounts for conversion features that are embedded within the Company’s convertible notes payable that do not have fixed settlement provisions as a separate derivative. In addition, warrants issued by the Company that do not have fixed settlement provisions are also treated as derivatives. The classification of derivatives, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative could be required within 12 months of the balance sheet date. STOCK-BASED COMPENSATION The Company accounts for share-based awards exchanged for employee services at the estimated grant date fair value of the award. The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Stock-based compensation charges are amortized over the vesting period or as earned. Stock-based compensation is recorded in the same component of operating expenses as if it were paid in cash. The Company generally issues new shares of common stock to satisfy conversion and warrant exercises. NET LOSS APPLICABLE TO COMMON SHAREHOLDERS PER SHARE Net loss applicable to common shareholders equals the Company’s net loss minus preferred stock dividends. Basic net loss applicable to common shareholders per share (“Basic net loss per share”) was computed using the weighted average number of common shares outstanding. Diluted net loss applicable to common shareholders per share (“Diluted net loss per share”) includes the effect of diluted common stock equivalents. Potentially dilutive securities from the exercise of stock options to purchase 365,385 shares of common stock and warrants to purchase 4,295,380 shares of common stock as of June 30, 2022, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. Potentially dilutive securities from the exercise of stock options to purchase 40,858 shares of common stock and warrants to purchase 937,813 shares of common stock as of June 30, 2021, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. RESEARCH AND DEVELOPMENT AND PRODUCT DEVELOPMENT COSTS Research and development costs are expenditures on new market development and related engineering costs. In addition to internal resources, the Company utilizes functional consulting resources, third-party software, and hardware development firms. The Company expenses all research and development costs as incurred until technological feasibility has been established for the product. Once technological feasibility is established, development costs including software and hardware design are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. For the six months ended June 30, 2022, the Company capitalized $269,268 of such product development costs. Amortization of these costs, which will be on a straight-line basis over three years, has not yet commenced. RECENT ACCOUNTING PRONOUNCEMENTS Recent accounting standards that have been issued or proposed by FASB (Financial Accounting Standards Board) or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption.

Accrued Expenses

Accrued Expenses	6 Months Ended
Accrued Expenses	Jun. 30, 2022
Payables and Accruals [Abstract]
ACCRUED EXPENSES	NOTE 5 - ACCRUED EXPENSES Accrued expenses consist of the following: June 30, December 31, 2022 2021 Salaries, payroll taxes and vacation $ 77,972 $ 54,229 Merchant card fees 20,044 17,853 Professional fees 243,206 104,500 Management incentives 312,200 285,000 Lease liability 69,771 64,346 Dividends – Series C and F Preferred Stock 46,735 94,933 Other 92,295 228,424 Totals $ 862,223 $ 849,285

Stockholders_ Equity and Redeem

Stockholders’ Equity and Redeemable Preferred Stock	6 Months Ended
Stockholders’ Equity and Redeemable Preferred Stock	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
STOCKHOLDERS’ EQUITY AND REDEEMABLE PREFERRED STOCK	NOTE 6 - STOCKHOLDERS’ EQUITY AND REDEEMABLE PREFERRED STOCK October 2021 Reverse stock split On October 15, 2021, the Company announced that its shareholders had approved a reverse split of its common stock and Series C Redeemable Preferred at a ratio of 1 for 10. As a result of the reverse split, every 10 pre-split shares of common stock outstanding and every 10 pre-split shares of Series C Redeemable Preferred Stock outstanding were automatically exchanged for one new share of each without any action on the part of the holders. The number of outstanding common shares was reduced from approximately 88.3 million shares to approximately 8.8 million shares, and the number of outstanding Series C preferred shares was reduced from 2,000 shares to 200 shares. The reverse stock split did not affect the total number of shares of capital stock, including Series C Redeemable Preferred Stock, that the company is authorized to issue. Loss per share and all share data for the three months and six months ended June 30, 2021, have been retroactively adjusted to reflect the reverse stock split in accordance with ASC 260-10-55-12, Restatement of EPS Data. September 2021 Offering On September 15, 2021, the Company sold an aggregate of (i) 2,788,750 shares of common stock, par value of $0.0001 per share, and (ii) accompanying warrants to purchase up to an aggregate of 2,788,750 shares of Common Stock, at an exercise price of $4.95 per share, both of which include the underwriter’s full over-allotment option to purchase an additional 363,750 shares of common stock. The Shares and the Warrants were offered and sold to the public pursuant to the Company’s registration statement on Form S-1, as amended (File No. 333-259105), filed by the Company with the Securities and Exchange Commission (SEC) under the Securities Act of 1933, as amended (Securities Act), which became effective on September 14, 2021. The Warrants were not immediately exercisable, as the Company did not have a sufficient number of shares of Common Stock to reserve for issuance for the Warrants until the date (the “Initial Exercise Date”) that the Company’s stockholders approved an amendment to the Company’s certificate of incorporation to affect a reverse stock split of the shares of Common Stock so that there were a sufficient number of shares of Common Stock for issuance upon exercise of the Warrants. The Warrants became exercisable on the Initial Exercise Date (the effective date of the reverse stock split) and will terminate five years after the Initial Exercise Date. The exercise price of the Warrants is subject to customary adjustments for stock dividends, stock splits and other subdivisions, combinations, and re-classifications, and was reset on the date of the Company’s reverse stock split to the lower of (i) the closing price per share of the Common Stock immediately before the reverse stock split, giving effect to the reverse stock split and (ii) the exercise price then in effect. The Warrants are also exercisable on a cashless basis under certain circumstances, any time after the Initial Exercise Date, pursuant to the formula outlined in the Warrants. On October 15, 2021, after shareholder and Board approval of the reverse stock split, the exercise price for the Warrants was adjusted to $3.956 per share, The reverse stock split and the exercise price were retroactively reported in accordance with ASC 260-10-55-12, Restatement of EPS Data. On the Closing Date, the Company received gross proceeds of approximately $12.5 million, before deducting underwriting discounts and commissions and estimated offering expenses. The Company intends to use the net proceeds from the Offering primarily for new product development, marketing, working capital, and liability reduction purposes. August 2021 Offering On August 13, 2021, the Company entered into a securities purchase agreement with institutional accredited investors providing for an aggregate investment of $4,000,000 for the issuance by the Company of (i) 1,333,333 shares of Series F Convertible Preferred Stock, par value $0.0001 per share, of the Company (the Series F Preferred Stock) convertible into shares of common stock, par value $0.0001 per share, of the Company that is issuable upon conversion of shares of Series F Preferred Stock; (ii) warrants, with a term of five and a half years exercisable after February 16, 2022, to purchase an aggregate of up to 666,667 shares of Common Stock at an exercise price of $7.80 per share. The securities issued to the investors were exempt from registration under the Securities Act of 1933, as amended, or the Securities Act, in reliance on Section 4(a)(2) thereof and Rule 506 of Regulation D thereunder, based on representations made by the investors, their prior relationship with the Company, and the absence of any general solicitation. The Company used the net proceeds from this offering for working capital and liability reduction purposes. In the three months ended September 30, 2021, 1,160,000 shares of Series F preferred stock were converted into 656,604 shares of common stock. On October 15, 2021, after shareholder and Board approval of the reverse stock split, the exercise price for the Warrants was adjusted to $4.95 per share and was retroactively reported in accordance with ASC 260-10-55-12, Restatement of EPS Data. For the three months and six months ended June 30, 2022, the Company recorded Series F Preferred Stock dividends of $13,144 and $26,145, respectively. February 2021 Offering On February 2, 2021, the Company closed a registered direct offering and concurrent private placement pursuant to which the Company issued (i) an aggregate of 1,476,016 shares of Series E preferred stock, convertible into up to 295,203 shares of common stock, (ii) common stock purchase warrants to purchase up to 100,000 shares of common stock at an exercise price of $12.30 per share, which were exercisable immediately and had a term of five years, and (iii) common stock purchase warrants to purchase up to 195,203 shares of common stock at an exercise price of $12.30 per share with a term of five and one-half years first exercisable nine months after issuance, for gross proceeds of $4,000,003, before deducting any offering expenses. The Company used the net proceeds from this offering for working capital and liability reduction purposes. In February 2021, 1,476,016 shares of Series E preferred stock were converted into 295,203 shares of common stock. Also in February 2021, the Company recorded a deemed dividend of $1,480,801 from the beneficial conversion feature associated with the issuance of the Series E convertible preferred stock and warrants. January 2021 Warrant exchange On January 8, 2021, the Company entered into a Warrant Amendment and Exercise Agreement (the “Amendment”) with holders (the “Holder”) of a common stock purchase warrant, dated April 4, 2019, previously issued by the Company (the “Original Warrant”). In consideration for each exercise of the Original Warrant within 45 calendar days of the Amendment, in addition to the issuance of the Warrant shares, the Company agreed to deliver a new warrant to purchase shares of the Company’s common stock equal to the number of Original Warrants that the Holder exercised, at an exercise price of $15.25 per share, which represents the average Nasdaq Official Closing Price of the common stock for the five trading days immediately preceding the date of the Amendment (the “New Warrants”). The Investor held Original Warrants exercisable for up to 246,913 shares of common stock, subsequently exercised 50,000 Original Warrants within the 45 days, and received 50,000 New Warrants in addition to the Warrant shares. Series C Redeemable Preferred Stock In May 2017, the Company authorized Series C Redeemable Preferred Stock. Holders of Series C Redeemable Preferred Stock are entitled to receive dividends of 15% per year, payable in cash. For the three and six months ended June 30, 2022, the Company recorded Series C Redeemable Preferred Stock dividends of $75,000 and $150,000, respectively. The Series C Redeemable Preferred Stock may be redeemed by the Company at the Company’s option in cash at any time, in whole or in part, upon payment of the stated value of the Series C Redeemable Preferred Stock and unpaid dividends. If a “fundamental change” occurs, the Series C Redeemable Preferred Stock shall be immediately redeemed in cash equal to the stated value of the Series C Redeemable Preferred Stock, and unpaid dividends. A fundamental change includes but is not limited to any change in the ownership of at least fifty percent of the voting stock; liquidation or dissolution, or the common stock ceases to be listed on the market upon which it currently trades. The holders of the Series C Redeemable Preferred Stock are entitled to vote on any matter submitted to the stockholders of the Company for a vote. One share of Series C Redeemable Preferred Stock carries the same voting rights as one share of common stock. Redeemable equity security is to be classified as temporary equity if it is conditionally redeemable upon the occurrence of an event that is not solely within the control of the issuer. Upon the determination that such events are probable, the equity security would be classified as a liability. Given that the Series C Redeemable Preferred Stock contains a fundamental change provision, the security is considered conditionally redeemable. Therefore, the Company has classified the Series C Redeemable Preferred Stock as temporary equity in the balance sheets on June 30, 2022, and December 31, 2021, until such time that events occur that indicate otherwise. Warrants There was no warrant activity during the six months ended June 30, 2022. The following table summarizes the Company’s warrants outstanding and exercisable on June 30, 2022, and December 31, 2021: Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Life In Years Aggregate Intrinsic Value Outstanding and Exercisable at January 1, 2021 1,569,007 $ 13.30 4.10 $ 10,850,158 Issued 3,897,534 $ 5.26 4.77 - Exercised (1,002,307 ) $ 9.07 - - Cancelled (168,854 ) $ 38.32 - - Outstanding and Exercisable at December 31, 2021 4,295,380 $ 6.02 4.59 - Outstanding and Exercisable at June 30, 2022 4,295,380 $ 6.02 4.27 $ 0.00

Stock Incentive Plans

Stock Incentive Plans	6 Months Ended
Stock Incentive Plans	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
STOCK INCENTIVE PLANS	NOTE 7 - STOCK INCENTIVE PLANS 2017 Stock Incentive Plan On August 24, 2017, the Company’s stockholders approved the 2017 Stock Incentive Plan (2017 SIP). The aggregate maximum number of shares of common stock that may be issued under the 2017 SIP is limited to 10% of the outstanding shares of common stock, calculated on the first business day of each fiscal year. Under the 2017 SIP, options that are forfeited or terminated, settled in cash in lieu of shares of common stock, or settled in a manner such that shares are not issued, will again immediately become available to be issued. If shares of common stock are withheld from payment of an award to satisfy tax obligations concerning the award, those shares of common stock will be treated as shares that have been issued under the 2017 SIP and will not again be available for issuance. During the quarter ended March 31, 2022, the Company issued 430,339 shares of common stock vesting over periods ranging from 30 to 48 months with an aggregate fair value of $1,331,870 to certain employees as inducement and incentive grants. During the quarter ended June 30, 2022, the Company issued 15,559 shares of common stock vesting on September 30, 2022 with an aggregate fair value of $17,582 to certain non-employees in lieu of cash payment for services. 2013 Long-Term Stock Incentive Plan On January 4, 2013, the Company’s stockholders approved the Company’s Long-Term Stock Incentive Plan (LTIP). The maximum number of shares of common stock that may be issued under the LTIP, including stock awards, stock issued to the Company’s Board, and stock appreciation rights, are limited to 10% of the common shares outstanding on the first business day of any fiscal year. During the three months ended March 31, 2022, the Company issued 237,500 stock options (5,000 of which were forfeited during the three months ended June 30, 2022) vesting over four years to employees with an exercise price of $3.36 and an option for 12,500 shares to a non-employee with a strike price of $2.20 and a total expense of $325,336. In addition, 27,276 fully vested stock options were granted to six non-employee Board directors at an exercise price of $2.20 during the three months ended March 31, 2022. The aggregate fair value of the shares issued to the directors was $51,187. A total of 22,101 stock options were granted to two Advisory Board members at strike prices ranging from $1.80 to $1.82 vesting over periods up to one year during the three months ended June 30, 2022. Stock-based Compensation Expense Total stock-based compensation expense during the six months ended June 30, 2022, pertaining to awards under the 2017 Stock Incentive Plan and 2013 Long-Term Stock Incentive Plan amounted to $743,919

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8 - COMMITMENTS AND CONTINGENCIES LEGAL MATTERS From time to time, the Company may be involved in various claims and legal actions arising in the ordinary course of our business. Other than the above, there is no action, suit, proceeding, inquiry, or investigation before or by any court, public board, government agency, self-regulatory organization, or body pending or, to the knowledge of the executive officers of the Company or any of our subsidiaries, threatened against or affecting our company, or any of our subsidiaries in which an adverse decision could have a material adverse effect upon our business, operating results, or financial condition. COMMITMENTS The Company leases office space and equipment, in the U.S., which is classified as operating leases expiring at various dates. The Company determines if an arrangement qualifies as a lease at the lease inception. Operating lease liabilities are recorded based on the present value of the future lease payments over the lease term, assessed as of the commencement date. The Company’s real estate lease, which is for office space and a fulfillment center, with a lease term of 5 years in August 2025. The Company also leases a copier with a lease term of 5 years, ending August 2023. The Company has elected to account for the lease and non-lease components (insurance and property taxes) as a single lease component for its real estate leases. Lease payments, which include lease components and non-lease components, are included in the measurement of the Company’s lease liabilities to the extent that such payments are either fixed amounts or variable amounts based on a rate or index (fixed in substance) as stipulated in the lease contract. Any actual costs over such amounts are expensed as incurred as variable lease costs. The Company’s lease agreements generally do not specify an implicit borrowing rate, and as such, the Company uses its incremental borrowing rate to calculate the present value of the future lease payments. The discount rate represents a risk-adjusted rate on a secured basis and is the rate at which the Company would borrow funds to satisfy the scheduled lease liability payment streams. The Company entered into a new five-year lease agreement in June 2020 for a new warehouse space located in Louisville, Kentucky. The monthly rent which commenced in September 2020 is $6,400 per month and increases approximately 3% annually thereafter. The ROU asset value-added because of this new lease agreement was $279,024. The Company’s ROU asset and lease liability accounts reflect the inclusion of this lease in the Company’s balance sheet as of June 30, 2022. The Company’s lease agreements include options for the Company to either renew or early terminate the lease. Renewal options are reviewed at lease commencement to determine if such options are reasonably certain of being exercised, which could impact the lease term. When determining if a renewal option is reasonably certain of being exercised, the Company considers several factors, including the significance of leasehold improvements on the property, whether the asset is difficult to replace, or specific characteristics unique to the lease that would make it reasonably certain that the Company would exercise the option. In most cases, the Company has concluded that renewal and early termination options are not reasonably certain of being exercised by the Company and thus not included in the Company’s ROU asset and lease liability. For the six months ended June 30, 2022, the total operating lease cost was $49,750 and is recorded in general and administrative expenses. The operating lease cost is recognized on a straight-line basis over the lease term. The following summarizes (i) the future minimum undiscounted lease payments under the non-cancelable lease for each of the next four years and thereafter, incorporating the practical expedient to account for lease and non-lease components as a single lease component for our existing real estate lease, (ii) a reconciliation of the undiscounted lease payments to the present value of the lease liabilities, and (iii) the lease-related account balances on the Company’s balance sheet as of June 30, 2022: Year Ending December 31, 2022 (excluding the six months ended June 30, 2022) $ 47,093 2023 89,724 2024 80,000 2025 54,400 Total future minimum lease payments $ 271,217 Less imputed interest (48,073 ) Total present value of future minimum lease payments $ 223,144 As of June 30, 2022 Operating lease right-of-use assets $ 216,345 Other accrued expenses $ 69,771 Other long-term liabilities 153,373 $ 223,144 As of June 30, 2022 Weighted Average Remaining Lease Term 2.99 Weighted Average Discount Rate 12.89 %

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
Accounting Policies, by Policy (Policies)	Jun. 30, 2022
Accounting Policies [Abstract]
USE OF ESTIMATES IN THE FINANCIAL STATEMENTS	USE OF ESTIMATES IN THE FINANCIAL STATEMENTS The preparation of financial statements in conformity with generally accepted accounting principles in the United States (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s management evaluates these significant estimates and assumptions, including those related to the fair value of acquired assets and liabilities, stock-based compensation, income taxes, allowance for doubtful accounts, long-lived assets, and inventories, and other matters that affect the financial statements and disclosures. Actual results could differ from those estimates.
CASH	CASH The Company considers all highly liquid securities with an original maturity date of three months or less when purchased to be cash equivalents. Due to their short-term nature, cash equivalents are carried at cost, which approximates fair value. On June 30, 2022, and December 31, 2021, the Company had no cash equivalents, respectively.
RESTRICTED CASH	RESTRICTED CASH On June 30, 2022, and December 31, 2021, the Company had restricted cash of $59,988 and $210,131, respectively. Restricted cash includes amounts held back by the Company’s third-party credit card processor for potential customer refunds, claims, and disputes and held as collateral for company credit cards.
CONCENTRATIONS OF CREDIT RISK	CONCENTRATIONS OF CREDIT RISK Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its cash balances in large well-established financial institutions located in the United States. At times, the Company’s cash balances may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (FDIC) insurance limits.
REVENUE RECOGNITION	REVENUE RECOGNITION The Company’s revenues consist of product sales to either end customers or distributors. The Company’s revenues are derived from contracts with customers, which are in most cases customer purchase orders. For each contract, the promise to transfer the control of the products, each of which is individually distinct, is considered to be the identified performance obligation. As part of the consideration promised in each contract, the Company evaluates the customer’s credit risk. Our contracts do not have any financing components, as payment terms are generally due Net-30 days after the invoice date. The Company’s products are almost always sold at fixed prices. In determining the transaction price, we evaluate whether the price is subject to any refunds, due to product returns or adjustments due to volume discounts, rebates, or price concessions to determine the net consideration we expect to be entitled to. The Company’s sales are recognized at a point-in-time under the core principle of recognizing revenue when control transfers to the customer, which generally occurs when the Company ships or delivers the product from its fulfillment center to our customers, when our customer accepts and has the legal title of the goods, and the Company has a present right to payment for such goods. Based on the respective contract terms, most of our contract revenues are recognized either (i) upon shipment based on free on board (FOB) shipping point, or (ii) when the product arrives at its destination. For the six months ended June 30, 2022, and 2021, none of our sales were recognized over time.
SALES TO DISTRIBUTORS AND RESELLERS	SALES TO DISTRIBUTORS AND RESELLERS Sales to certain distributors and resellers are made under terms allowing limited rights of return of the Company’s products held in their inventory or upon sale to their end customers. The Company maintains a reserve for unprocessed and estimated future price adjustments claims and returns as a refund liability. The reserve is recorded as a reduction to revenue in the same period that the related revenue is recorded and is calculated based on an analysis of historical claims and returns over a period of time to appropriately account for current pricing and business trends. Similarly, sales returns and allowances are recorded based on historical return rates, as a reduction in revenue with a corresponding reduction to cost of sales for the estimated cost of inventory that is expected to be returned. These reserves were not material on the Condensed Balance Sheets on June 30, 2022, and December 31, 2021.
SHIPPING AND HANDLING	SHIPPING AND HANDLING Amounts billed to customers for shipping and handling are included in revenues. The related freight charges incurred by the Company are included in the cost of goods sold and were $181,551 and $373,213, respectively, for the three and six months ended June 30, 2022, and $118,136 and $224,561, respectively, for the three and six months ended June 30, 2021.
ACCOUNTS RECEIVABLE	ACCOUNTS RECEIVABLE For the three and six months ended June 30, 2022, and the year ended December 31, 2021, the Company’s revenues primarily included shipments of the LogicMark products. The terms and conditions of these sales provided certain customers with trade credit terms. In addition, these sales were made to the retailers with no rights of return and are subject to the normal warranties offered to the ultimate consumer for product defects. Accounts receivable are stated at net realizable value. The Company regularly reviews accounts receivable balances and adjusts the receivable reserves as necessary whenever events or circumstances indicate the carrying value may not be recoverable. On June 30, 2022, and December 31, 2021, the Company had an allowance for doubtful accounts of $3,209 and $5,411, respectively.
INVENTORY	INVENTORY The Company measures inventory at the lower of cost or net realizable value, defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The Company performs regular reviews of inventory quantities on hand and evaluates the realizable value of its inventories. The Company adjusts the carrying value of the inventory as necessary with estimated valuation reserves for excess, obsolete, and slow-moving inventory by comparing the individual inventory parts to forecasted product demand or production requirements. The inventory is valued at the lower of cost or net realizable value with cost determined using the first-in, first-out method. As of June 30, 2022, inventory was comprised of $622,893 in finished goods on hand. As of December 31, 2021, inventory was comprised of $1,237,280 in finished goods on hand. The Company is required to prepay for certain inventory with certain vendors until credit terms can be established. As of June 30, 2022, and December 31, 2021, $599,112 and $559,938 respectively, of prepayments made for inventory are included in prepaid expenses and other current assets on the balance sheet.
LONG-LIVED ASSETS	LONG-LIVED ASSETS Long-lived assets, such as property and equipment, and other intangibles are evaluated for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. When indicators exist, the Company tests for the impairment of the definite-lived assets based on the undiscounted future cash flow the assets are expected to generate over their remaining useful lives, compared to the carrying value of the assets. If the carrying amount of the assets is determined not to be recoverable, a write-down to fair value is recorded. Management estimates future cash flows using assumptions about expected future operating performance. Management’s estimates of future cash flows may differ from actual cash flow due to, among other things, technological changes, economic conditions, or changes to the Company’s business operations.
PROPERTY AND EQUIPMENT	PROPERTY AND EQUIPMENT Property and equipment consisting of equipment, furniture and fixtures, and website and other are stated at cost. The costs of additions and improvements are generally capitalized and expenditures for repairs and maintenance are expensed in the period incurred. When items of property and equipment are sold or retired, the related costs and accumulated depreciation are removed from the accounts, and any gain or loss is included in income. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful life of the respective asset as follows: Equipment 5 years Furniture and fixtures 3 to 5 years Website and other 2 to 3 years
GOODWILL	GOODWILL Goodwill is reviewed annually in the fourth quarter, or when circumstances indicate that an impairment may have occurred. The Company first performs a qualitative assessment of goodwill impairment, which considers factors such as market conditions, performance compared to forecast, business outlook, and unusual events. If the qualitative assessment indicates a possible goodwill impairment, goodwill is then quantitatively tested for impairment. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative test. If a quantitative goodwill impairment test is required, the fair value is determined using a variety of assumptions including estimated future cash flows using applicable discount rates (income approach) and comparisons to other similar companies (market approach).
OTHER INTANGIBLE ASSETS	OTHER INTANGIBLE ASSETS The Company’s intangible assets are related to the acquisition of LogicMark, LLC and are included in other intangible assets in the Company’s balance sheet on June 30, 2022, and December 31, 2021. On June 30, 2022, Other intangible assets, net of amortization, are comprised of patents of $1,887,784; trademarks of $883,579; and customer relationships of $1,321,808. On December 31, 2021, the other intangible assets are comprised of patents of $2,072,984; trademarks of $915,619; and customer relationships of $1,488,044. The Company amortizes these intangible assets using the straight-line method over their estimated useful lives which for the patents, trademarks, and customer relationships are 11 years, 20 years, and 10 years, respectively. During the three and six months ended June 30, 2022, the Company recorded amortization expense of $194,178 and $388,284, respectively. During the three and six months ended June 30, 2021, the Company recorded amortization expense of $189,932 and $377,777, respectively. As of June 30, 2022, total amortization expense estimated for the remainder of fiscal year 2022 is $373,531, and for each of the next five fiscal years, the total amortization expense is estimated to be as follows: 2023 - $761,815; 2024 - $761,815; 2025 - $761,815; 2026 - $618,790; and 2027- $272,235.
CONVERTIBLE INSTRUMENTS	CONVERTIBLE INSTRUMENTS The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion options. The accounting standards require companies to separate conversion options from their host instruments and account for them as free-standing derivatives according to certain criteria. The criteria include circumstances in which (i) the economic characteristics and risks of the embedded derivative are not closely related to the economic characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative and the host contract is not re-measured at fair value under generally accepted accounting principles with changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative would be considered a derivative. The derivative is subsequently marked to market at each reporting date based on the current fair value, with the changes in fair value reported in the results of operations. Conversion options with variable settlement features such as provisions to adjust the conversion price upon subsequent issuances at exercise prices more favorable than that in the hybrid contract generally result in their separation from the host instrument. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. The debt discounts under these arrangements are amortized over the earlier of (i) the term of the related debt using the straight-line method which approximates the interest rate method or (ii) conversion of the debt. The amortization of debt discount is included as interest expense included in other income and expenses in the statements of operations.
DERIVATIVE FINANCIAL INSTRUMENTS	DERIVATIVE FINANCIAL INSTRUMENTS The Company does not use derivatives to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. Derivative financial instruments accounted for as liabilities are initially recorded at fair value and then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivatives, the Company uses the Black-Scholes or binomial option valuation model to value the derivatives at inception and on subsequent valuation dates. The Company accounts for conversion features that are embedded within the Company’s convertible notes payable that do not have fixed settlement provisions as a separate derivative. In addition, warrants issued by the Company that do not have fixed settlement provisions are also treated as derivatives. The classification of derivatives, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative could be required within 12 months of the balance sheet date.
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION The Company accounts for share-based awards exchanged for employee services at the estimated grant date fair value of the award. The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Stock-based compensation charges are amortized over the vesting period or as earned. Stock-based compensation is recorded in the same component of operating expenses as if it were paid in cash. The Company generally issues new shares of common stock to satisfy conversion and warrant exercises.
NET LOSS APPLICABLE TO COMMON SHAREHOLDERS PER SHARE	NET LOSS APPLICABLE TO COMMON SHAREHOLDERS PER SHARE Net loss applicable to common shareholders equals the Company’s net loss minus preferred stock dividends. Basic net loss applicable to common shareholders per share (“Basic net loss per share”) was computed using the weighted average number of common shares outstanding. Diluted net loss applicable to common shareholders per share (“Diluted net loss per share”) includes the effect of diluted common stock equivalents. Potentially dilutive securities from the exercise of stock options to purchase 365,385 shares of common stock and warrants to purchase 4,295,380 shares of common stock as of June 30, 2022, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. Potentially dilutive securities from the exercise of stock options to purchase 40,858 shares of common stock and warrants to purchase 937,813 shares of common stock as of June 30, 2021, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive.
RESEARCH AND DEVELOPMENT AND PRODUCT DEVELOPMENT COSTS	RESEARCH AND DEVELOPMENT AND PRODUCT DEVELOPMENT COSTS Research and development costs are expenditures on new market development and related engineering costs. In addition to internal resources, the Company utilizes functional consulting resources, third-party software, and hardware development firms. The Company expenses all research and development costs as incurred until technological feasibility has been established for the product. Once technological feasibility is established, development costs including software and hardware design are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. For the six months ended June 30, 2022, the Company capitalized $269,268 of such product development costs. Amortization of these costs, which will be on a straight-line basis over three years, has not yet commenced.
RECENT ACCOUNTING PRONOUNCEMENTS	RECENT ACCOUNTING PRONOUNCEMENTS Recent accounting standards that have been issued or proposed by FASB (Financial Accounting Standards Board) or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	6 Months Ended
Summary of Significant Accounting Policies (Tables)	Jun. 30, 2022
Accounting Policies [Abstract]
Schedule of estimated useful life of property and equipment	Equipment 5 years Furniture and fixtures 3 to 5 years Website and other 2 to 3 years

Accrued Expenses (Tables)

Accrued Expenses (Tables)	6 Months Ended
Accrued Expenses (Tables)	Jun. 30, 2022
Payables and Accruals [Abstract]
Schedule of accrued expenses	June 30, December 31, 2022 2021 Salaries, payroll taxes and vacation $ 77,972 $ 54,229 Merchant card fees 20,044 17,853 Professional fees 243,206 104,500 Management incentives 312,200 285,000 Lease liability 69,771 64,346 Dividends – Series C and F Preferred Stock 46,735 94,933 Other 92,295 228,424 Totals $ 862,223 $ 849,285

Stockholders_ Equity and Rede_2

Stockholders’ Equity and Redeemable Preferred Stock (Tables)	6 Months Ended
	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Schedule of warrants outstanding and exercisable	Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Life In Years Aggregate Intrinsic Value Outstanding and Exercisable at January 1, 2021 1,569,007 $ 13.30 4.10 $ 10,850,158 Issued 3,897,534 $ 5.26 4.77 - Exercised (1,002,307 ) $ 9.07 - - Cancelled (168,854 ) $ 38.32 - - Outstanding and Exercisable at December 31, 2021 4,295,380 $ 6.02 4.59 - Outstanding and Exercisable at June 30, 2022 4,295,380 $ 6.02 4.27 $ 0.00

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
Commitments and Contingencies (Tables)	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of future lease obligation	Year Ending December 31, 2022 (excluding the six months ended June 30, 2022) $ 47,093 2023 89,724 2024 80,000 2025 54,400 Total future minimum lease payments $ 271,217 Less imputed interest (48,073 ) Total present value of future minimum lease payments $ 223,144
Schedule of lease expense	As of June 30, 2022 Operating lease right-of-use assets $ 216,345 Other accrued expenses $ 69,771 Other long-term liabilities 153,373 $ 223,144 As of June 30, 2022 Weighted Average Remaining Lease Term 2.99 Weighted Average Discount Rate 12.89 %

Liquidity and Management Plans

Liquidity and Management Plans (Details) - USD ($)	6 Months Ended
Liquidity and Management Plans (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Liquidity and Management Plans Table [Abstract]
Operating loss	$ (2,408,576)
Net loss	2,395,417
Cash	11,144,085
Stockholders’ equity	24,761,528
Working capital	$ 11,208,250	$ 13,098,049

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Product Information [Line Items]
Restricted cash	$ 59,988		$ 59,988		$ 210,131
Freight charges	181,551	$ 118,136	373,213	$ 224,561
Allowance for doubtful accounts	3,209		3,209		5,411
Inventory finished goods	622,893		622,893		1,237,280
Prepaid expenses and other current assets	599,112		599,112		559,938
Amortization expense	194,178	$ 189,932	388,284	$ 377,777
Amortization expense estimated for 2022	373,531		373,531
Amortization expense estimated for 2023	761,815		761,815
Amortization expense estimated for 2024	761,815		761,815
Amortization expense estimated for 2025	761,815		761,815
Amortization expense estimated for 2026	618,790		618,790
Amortization expense estimated for 2027	$ 272,235		$ 272,235
Stock options purchase (in Shares)			365,385	40,858
Development costs			$ 269,268
Warrant [Member]
Product Information [Line Items]
Warrants purchase (in Shares)	4,295,380	937,813	4,295,380	937,813
Logic Mark [Member] \| Patents [Member]
Product Information [Line Items]
Intangible assets of patents	$ 1,887,784		$ 1,887,784		2,072,984
Other intangible assets, estimated useful lives			11 years
Logic Mark [Member] \| Trademarks [Member]
Product Information [Line Items]
Intangible assets trademarks	883,579		$ 883,579		915,619
Other intangible assets, estimated useful lives			20 years
Logic Mark [Member] \| Customer Relationships [Member]
Product Information [Line Items]
Intangible assets customer relationships	$ 1,321,808		$ 1,321,808		$ 1,488,044
Other intangible assets, estimated useful lives			10 years

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of estimated useful life of property and equipment	6 Months Ended
	Jun. 30, 2022
Equipment [Member]
Public Utility, Property, Plant and Equipment [Line Items]
Estimated useful life	5 years
Furniture and Fixtures [Member] \| Minimum [Member]
Public Utility, Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Furniture and Fixtures [Member] \| Maximum [Member]
Public Utility, Property, Plant and Equipment [Line Items]
Estimated useful life	5 years
Website and Other [Member] \| Minimum [Member]
Public Utility, Property, Plant and Equipment [Line Items]
Estimated useful life	2 years
Website and Other [Member] \| Maximum [Member]
Public Utility, Property, Plant and Equipment [Line Items]
Estimated useful life	3 years

Accrued Expenses (Details) - Sc

Accrued Expenses (Details) - Schedule of accrued expenses - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Schedule of accrued expenses [Abstract]
Salaries, payroll taxes and vacation	$ 77,972	$ 54,229
Merchant card fees	20,044	17,853
Professional fees	243,206	104,500
Management incentives	312,200	285,000
Lease liability	69,771	64,346
Dividends – Series C and F Preferred Stock	46,735	94,933
Other	92,295	228,424
Totals	$ 862,223	$ 849,285

Stockholders_ Equity and Rede_3

Stockholders’ Equity and Redeemable Preferred Stock (Details) - USD ($)				1 Months Ended	3 Months Ended		6 Months Ended
	Oct. 15, 2021	Feb. 02, 2021	May 01, 2017	Sep. 15, 2021	Jun. 30, 2022	Sep. 30, 2021	Jun. 30, 2022	Dec. 31, 2021	Aug. 13, 2021
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Reverse stock split, description	the Company announced that its shareholders had approved a reverse split of its common stock and Series C Redeemable Preferred at a ratio of 1 for 10. As a result of the reverse split, every 10 pre-split shares of common stock outstanding and every 10 pre-split shares of Series C Redeemable Preferred Stock outstanding were automatically exchanged for one new share of each without any action on the part of the holders.
Common stock shares outstanding					9,608,937		9,608,937	9,163,039
Common stock, par value (in Dollars per share)					$ 0.0001		$ 0.0001	$ 0.0001
Gross proceeds (in Dollars)				$ 12,500,000
Investment (in Dollars)									$ 4,000,000
Preferred stock, par value (in Dollars per share)					$ 0.0001		$ 0.0001	$ 0.0001
Voting rights, description							One share of Series C Redeemable Preferred Stock carries the same voting rights as one share of common stock.
Maximum [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Common stock shares outstanding	88,300,000
Minimum [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Common stock shares outstanding	8,800,000
Series C Preferred Stock [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Preference stock shares outstanding					200		200	200
Preferred stock, par value (in Dollars per share)					$ 0.0001		$ 0.0001	$ 0.0001
Series C Preferred Stock [Member] \| Maximum [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Preference stock shares outstanding	2,000
Series C Preferred Stock [Member] \| Minimum [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Preference stock shares outstanding	200
Series F Preferred Stock [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Preference stock shares outstanding					173,333		173,333	173,333
Preferred stock, par value (in Dollars per share)					$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock dividends (in Dollars)					$ 13,144		$ 26,145
Series C Redeemable Preferred Stock [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Preferred stock dividends (in Dollars)					$ 75,000		$ 150,000
Cumulative dividends rate			15%
September 2021 Offering [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Aggregate of sale, shares				2,788,750
Common stock, par value (in Dollars per share)				$ 0.0001
Aggregate of purchase shares				2,788,750
Exercise price per share (in Dollars per share)				$ 4.95
Additional shares of common stock				363,750
Warrant exercise price (in Dollars per share)	$ 3.956
August 2021 Offering [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Common stock, par value (in Dollars per share)									$ 0.0001
Shares issued									1,333,333
Preferred stock, par value (in Dollars per share)									$ 0.0001
Common stock, shares issued						656,604			666,667
Common stock exercise price per share (in Dollars per share)									$ 7.8
Preferred stock, shares issued						1,160,000
Warrants per share (in Dollars per share)	$ 4.95
February 2021 Offering [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Registered direct offering, description		(i) an aggregate of 1,476,016 shares of Series E preferred stock, convertible into up to 295,203 shares of common stock, (ii) common stock purchase warrants to purchase up to 100,000 shares of common stock at an exercise price of $12.30 per share, which were exercisable immediately and had a term of five years, and (iii) common stock purchase warrants to purchase up to 195,203 shares of common stock at an exercise price of $12.30 per share with a term of five and one-half years first exercisable nine months after issuance, for gross proceeds of $4,000,003, before deducting any offering expenses. The Company used the net proceeds from this offering for working capital and liability reduction purposes. In February 2021, 1,476,016 shares of Series E preferred stock were converted into 295,203 shares of common stock. Also in February 2021, the Company recorded a deemed dividend of $1,480,801 from the beneficial conversion feature associated with the issuance of the Series E convertible preferred stock and warrants.
January 2021 Warrant exchange [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Common stock, shares issued					246,913		246,913
Common stock exercise price per share (in Dollars per share)					$ 15.25		$ 15.25
Original warrants							50,000
Addition of warrants							50,000

Stockholders_ Equity and Rede_4

Stockholders’ Equity and Redeemable Preferred Stock (Details) - Schedule of warrants outstanding and exercisable - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Number of Warrants [Member]
Class of Warrant or Right [Line Items]
Number of Warrants, Outstanding	4,295,380	1,569,007
Number of Warrants, Issued		3,897,534
Number of Warrants, Exercised		(1,002,307)
Number of Warrants, Cancelled		(168,854)
Number of Warrants, Outstanding	4,295,380	4,295,380
Weighted Average Exercise Price [Member]
Class of Warrant or Right [Line Items]
Weighted Average Exercise Price, Outstanding	$ 6.02	$ 13.3
Weighted Average Exercise Price, Issued		5.26
Weighted Average Exercise Price, Exercised		9.07
Weighted Average Exercise Price, Cancelled		38.32
Weighted Average Exercise Price, Outstanding	$ 6.02	$ 6.02
Weighted Average Remaining Life In Years [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Life In Years, Outstanding		4 years 1 month 6 days
Weighted Average Remaining Life In Years, Issued		4 years 9 months 7 days
Weighted Average Remaining Life In Years, Exercised
Weighted Average Remaining Life In Years, Cancelled
Weighted Average Remaining Life In Years, Outstanding	4 years 3 months 7 days	4 years 7 months 2 days
Aggregate Intrinsic Value [Member]
Class of Warrant or Right [Line Items]
Aggregate Intrinsic Value, Outstanding		$ 10,850,158
Aggregate Intrinsic Value, Issued
Aggregate Intrinsic Value, Exercised
Aggregate Intrinsic Value, Cancelled
Aggregate Intrinsic Value, Outstanding	$ 0

Stock Incentive Plans (Details)

Stock Incentive Plans (Details) - USD ($)		1 Months Ended	3 Months Ended		6 Months Ended
Stock Incentive Plans (Details) - USD ($)	Jan. 04, 2013	Aug. 24, 2017	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022
2017 Stock Incentive Plan [Member]
Stock Incentive Plans (Details) [Line Items]
Common shares outstanding, percentage		10%
Number of options vested				430,339
Stock fair value (in Dollars)			$ 17,582	$ 1,331,870
Number of stock options vested			15,559		15,559
Total stock-based compensation expense (in Dollars)					$ 743,919
2013 Long-Term Stock Incentive Plan [Member]
Stock Incentive Plans (Details) [Line Items]
Common shares outstanding, percentage	10%
Shares issued of stock options				237,500
Forfeited shares			5,000
Stock options vesting term				4 years
Exercise price (in Dollars per share)				$ 3.36
Number of shares option				12,500
Strike price per share (in Dollars per share)				$ 2.2
Total expense (in Dollars)				$ 325,336
Vested stock options shares				27,276
Directors exercise price (in Dollars per share)				$ 2.2
Aggregate fair value (in Dollars)				$ 51,187
Stock option granted				22,101
2013 Long-Term Stock Incentive Plan [Member] \| Minimum [Member]
Stock Incentive Plans (Details) [Line Items]
Strike price (in Dollars per share)			$ 1.8
2013 Long-Term Stock Incentive Plan [Member] \| Maximum [Member]
Stock Incentive Plans (Details) [Line Items]
Strike price (in Dollars per share)			$ 1.82

Commitments and Contingencies_2

Commitments and Contingencies (Details) - USD ($)	1 Months Ended	6 Months Ended
Commitments and Contingencies (Details) - USD ($)	Sep. 30, 2020	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Real estate lease term, description		The Company’s real estate lease, which is for office space and a fulfillment center, with a lease term of 5 years in August 2025. The Company also leases a copier with a lease term of 5 years, ending August 2023.
Monthly rent	$ 6,400
Increasing annual rent, percentage	3%
ROU asset value-added	$ 279,024
Operating lease cost		$ 49,750

Commitments and Contingencies_3

Commitments and Contingencies (Details) - Schedule of future lease obligation	Jun. 30, 2022 USD ($)
Schedule of future lease obligation [Abstract]
2022 (excluding the six months ended June 30, 2022)	$ 47,093
2023	89,724
2024	80,000
2025	54,400
Total future minimum lease payments	271,217
Less imputed interest	(48,073)
Total present value of future minimum lease payments	$ 223,144

Commitments and Contingencies_4

Commitments and Contingencies (Details) - Schedule of lease expense - Operating Expense [Member]	Jun. 30, 2022 USD ($)
Commitments and Contingencies (Details) - Schedule of lease expense [Line Items]
Operating lease right-of-use assets	$ 216,345
Other accrued expenses	69,771
Other long-term liabilities	153,373
Total	$ 223,144
Weighted Average Remaining Lease Term	2 years 11 months 26 days
Weighted Average Discount Rate	12.89%